Generation Bio (GBIO) Equity Average (2021 - 2025)
Historic Equity Average for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to $52.3 million.
- Generation Bio's Equity Average fell 5239.41% to $52.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.3 million, marking a year-over-year decrease of 5239.41%. This contributed to the annual value of $144.7 million for FY2024, which is 4042.02% down from last year.
- According to the latest figures from Q3 2025, Generation Bio's Equity Average is $52.3 million, which was down 5239.41% from $63.7 million recorded in Q2 2025.
- In the past 5 years, Generation Bio's Equity Average ranged from a high of $446.1 million in Q2 2021 and a low of $52.3 million during Q3 2025
- For the 5-year period, Generation Bio's Equity Average averaged around $237.8 million, with its median value being $254.9 million (2023).
- In the last 5 years, Generation Bio's Equity Average plummeted by 2129.91% in 2023 and then plummeted by 5617.76% in 2024.
- Quarter analysis of 5 years shows Generation Bio's Equity Average stood at $394.5 million in 2021, then fell by 25.06% to $295.6 million in 2022, then fell by 26.42% to $217.5 million in 2023, then crashed by 56.18% to $95.3 million in 2024, then tumbled by 45.1% to $52.3 million in 2025.
- Its Equity Average stands at $52.3 million for Q3 2025, versus $63.7 million for Q2 2025 and $79.8 million for Q1 2025.